粪便钙卫蛋白检测在炎症性肠病患者中的意义

被引：4

作者：

董伟华 ^{[1
]}

陈瑞东 ^{[2
]}

唐文 ^{[2
]}

机构：

[1] 苏州市吴江区中西医结合医院

[2] 苏州大学附属第医院

来源：

临床消化病杂志 | 2019年 / 31卷 / 06期

关键词：

炎症性肠病; 克罗恩病; 结肠炎,溃疡性; 粪便钙卫蛋白;

D O I：

暂无

中图分类号：

R574 [肠疾病];

学科分类号：

100201 [内科学];

摘要：

<正>炎症性肠病(inflammatory bowel diseases,IBD)包括克罗恩病(Crohn’s disease,CD)和溃疡性结肠炎(ulceralive colitis,UC),是一种慢性非特异性肠道炎症性疾病,以反复复发为特点,对于IBD疾病的管理,一直是临床医生面临的难题,目前临床上常用的评估病情手段有内镜、血清学指标、影像

引用

页码：406 / 409

页数：4

共 16 条

[1]

Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients [J].

Lin, Wei-Chen ;

Wong, Jau-Min ;

Tung, Chien-Chih ;

Lin, Ching-Pin ;

Chou, Jen-Wei ;

Wang, Horng-Yuan ;

Shieh, Ming-Jium ;

Chang, Chin-Hao ;

Liu, Heng-Hsiu ;

Wei, Shu-Chen .

WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (48) :13566-13573

[2]

钙卫蛋白在炎性疾病中的表达及临床意义 [J].

王旭 ;

黄立锋 .

国际免疫学杂志, 2015, 38 (04)

[3]

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.[J].Sun-Ho Lee;Min-Ju Kim;Kiju Chang;Eun Mi Song;Sung Wook Hwang;Sang Hyoung Park;Dong-Hoon Yang;Kyung-Jo Kim;Jeong-Sik Byeon;Seung-Jae Myung;Suk-Kyun Yang;Byong Duk Ye.BMC Gastroenterology.2017, 1

[4]

Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study [J].

Ye, Lei ;

Chen, Bi Qin ;

Wang, Shao Dong ;

Shi, Hui ;

Yang, Zhao ;

Wang, Fang Yu .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (10) :1113-1119

[5]

Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission [J].

Kim, Jae Hyun ;

Cheon, Jae Hee ;

Park, Yehyun ;

Lee, Hyun Jung ;

Park, Soo Jung ;

Kim, Tae Il ;

Kim, Won Ho .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) :1069-1074

[6]

Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis [J].

Yamaguchi, Sayaka ;

Takeuchi, Yoshiaki ;

Arai, Katsuhito ;

Fukuda, Katsuyuki ;

Kuroki, Yuichiro ;

Asonuma, Kunio ;

Takahashi, Hiroshi ;

Saruta, Masayuki ;

Yoshida, Hitoshi .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (01) :93-98

[7]

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year [J].

Guidi, Luisa ;

Marzo, Manuela ;

Andrisani, Gianluca ;

Felice, Carla ;

Pugliese, Daniela ;

Mocci, Giammarco ;

Nardone, Olga ;

De Vitis, Italo ;

Papa, Alfredo ;

Rapaccini, Gianlodovico ;

Forni, Franca ;

Armuzzi, Alessandro .

DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) :974-979

[8]

Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50<ce:hsp sp="0.25"/>years.[J].Nicholas A. Kennedy;Annalie Clark;Andrew Walkden;Jeff C.W. Chang;Federica Fascí-Spurio;Martina Muscat;Brydon W. Gordon;Kathleen Kingstone;Jack Satsangi;Ian D.R. Arnott;Charlie W. Lees.Journal of Crohn's and Colitis.2014, 1

[9]

Mucosal Healing As a Target of Therapy for Colonic Inflammatory Bowel Disease and Methods to Score Disease Activity.[J].Alissa Walsh;Rebecca Palmer;Simon Travis.Gastrointestinal Endoscopy Clinics of North America.2014, 3

[10]

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study [J].

Yamamoto, Takayuki ;

Shiraki, Manabu ;

Bamba, Takuya ;

Umegae, Satoru ;

Matsumoto, Koichi .

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2013, 1 (05) :368-374

← 1 2 →